Similar A1C Outcomes in Type 1 Diabetic Patients Undergoing Intensive Diabetes Management with Preprandial Rapid-Acting Insulin and Either CSII or Glargine [2]

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 272-273

  Harmel, Anne Peters ^a   Mathur, Ruchi ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO;

CONTINUOUS INFUSION; DIABETES MELLITUS; DRUG FORMULATION; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN INFUSION; INSULIN TREATMENT; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; TREATMENT OUTCOME;

EID: 1042280185     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.272-a     Document Type: Letter

References (2)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 289:2254-2264, 2003